scPharmaceuticals LLC announced two executive appointments reflecting the evolution of the company from a development oriented company to a commercially focused organization. Abraham (Abe) Ceesay was appointed Chief Operating Officer and Troy Ignelzi was named Chief Financial Officer. Prior to joining scPharmaceuticals, Mr. Ceesay served as Vice President, Sales, Marketing, and Commercial Operations at Keryx Biopharmaceuticals where he developed the commercial organization and strategy for the company's inaugural product Auryxia.

Troy Ignelzi joins the Company from Juventas Therapeutics as Chief Financial Officer where he successfully completed venture debt and equity financings.